Translational Physician-Scientist Training Program in Oncology

肿瘤学转化医师科学家培训计划

• 批准号: 8735882
• 负责人: DONG M SHIN
• 金额: $ 27.24万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-17 至 2018-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8735882
• 关键词: Physicians; Scientist; Training Programs; oncology

DESCRIPTION (provided by applicant): The Department of Hematology and Medical Oncology (HMO) and the Winship Cancer Institute at Emory University proposes a T32 Translational Physician-Scientist Training Program in Oncology. This 2.5-year Training Program (including 6 months funded internally by the HMO Department, and 2 years of T32 funding support) will enable hematology/oncology fellows to acquire a strong education in basic/translational research approaches, with the ultimate goal of establishing an independent research program for each trainee. Many studies have documented the attrition of the physician-scientist pipeline, due in large part to the challenges faced in obtaining grant funding. Providing a high level of mentoring and support is necessary to nurture the development of young physician-scientists and retain them in academic institutions. The Training Program aims to (1) provide a sufficiently large mentor pool from which to select the most appropriate research topic(s) for each trainee; (2) foster a multidisciplinary approach to cancer care and patient-oriented research through interaction with basic and clinical investigators of diverse specialties; (3) provide guidance in research design, methodology and analysis that will foster the independence of developing physician-scientists in the field of translational oncology, focused on solid tumors mainly including head and neck, lung, breast, gastrointestinal and genitourinary malignancies; and (4) guide trainees through the development and submission of their first grant application(s). The Training Program will recruit 2 residents per year with 2-3 years of prior clinical training in internal medicine, a strong desire to develop basic science research skills in oncology, and a commitment to academic medicine. All trainees will initially be recruited to the existing Hematology/Oncology Fellowship Program, and will first complete 18 months of clinical requirements for the fellowship in PGY-4 and the first half of PGY-5 (to fulfill the board eligibilty requirements of the ACGME). Trainees will then undertake 2.5 years of T32 Training Program research, from the second half of PGY-5 through PGY-7, which will encompass close mentoring in research design, methodology and analysis, support in career development and grant preparation, and participation in a rigorously defined training curriculum. Training will focus on elements critical for a successful academic career, particularly progress towards conference presentations, manuscript publications, and applications for independent research funding. Through its strong commitment to the proposed Translational Physician-Scientist Training Program in Oncology, the Emory HMO Department and the Winship intend to actively contribute to training and mentoring the next generation of physician-scientist oncologists, supporting them in the early steps of their academic research careers.

描述（由申请人提供）：血液学和医学肿瘤学系（HMO）和埃默里大学的Winship Cancer Institute提出了T32转化医师 - 科学家肿瘤学培训计划。这个2。5年的培训计划（包括由HMO部门内部资助的6个月，以及2年的T32资金支持）将使血液学/肿瘤学研究员能够在基本/翻译研究方法中获得强大的教育，并最终的目标是为每个受训者建立一个独立的研究计划。许多研究记录了医师科学家管道的流失，这在很大程度上是由于获得赠款资金所面临的挑战。 为了培养年轻医师科学家的发展并将其保留在学术机构中，提供高水平的指导和支持是必要的。 该培训计划的目的是（1）提供一个足够大的导师池，从中为每个学员选择最合适的研究主题； （2）通过与不同专业的基本和临床研究者的互动来培养一种多学科护理和面向患者的研究的多学科方法； （3）提供研究设计，方法论和分析的指导，这些指导将促进转化肿瘤学领域发展医师科学家的独立性，该领域的重点是主要的实体瘤，包括头颈，肺，乳房，乳房，胃肠道和泌尿生殖力恶性肿瘤； （4）指导学员通过开发和提交其第一个赠款申请。 该培训计划将每年招募2名居民，并在内科医学领域进行2 - 3年的先前临床培训，这是发展基础科学研究技能的强烈愿望 肿瘤学和对学术医学的承诺。最初，所有学员将被招募到现有的血液学/肿瘤学奖学金计划中，并将首先完成18个月的PGY-4奖学金和PGY-5上半年临床要求（以满足ACGME的董事会Eligibilty要求）。然后，学员将进行2。5年的T32培训计划研究，从PGY-5的下半年到PGY-7，该研究将涵盖研究设计，方法论和分析，职业发展和赠款准备工作以及参与严格定义的培训课程的密切指导。培训将重点关注成功的学术职业至关重要的要素，尤其是在会议演讲，手稿出版物和独立研究资金的应用方面的进步。 通过对拟议的肿瘤学转化医师科学培训计划的坚定承诺，埃默里HMO部门和Winship打算积极贡献培训和指导下一代医师科学家肿瘤学家，并在其学术研究职业的早期步骤中支持他们。